Stockchase Opinions

Michael Sprung HCA Healthcare HCA-N HOLD Apr 15, 2003

Disappointed on the earnings. Should be near their bottom now.
$28.900

Stock price when the opinion was issued

medical services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

PAST TOP PICK
(A Top Pick May 28/03. Up 18%.) When the economy went into a downturn, they got out.
TOP PICK

Healthcare has been a big focus of his. This is the largest hospital management companies in the US, even if only 5% of the market, so there is lots of room for growth. The US population is aging. This is a steady, non-economically sensitive company.

PAST TOP PICK

(A Top Pick Aug 13/15. Down 11.51%.) This has been dead quiet over the course of the last year. It had a lift through November-February, and then basically has consolidated ever since. The group is actually starting to look quite interesting. The sector has been improving from a relative strength standpoint, since June. This could still be a Buy at these levels.

BUY
This got upgraded yesterday, and he thinks it will go to $200.
TOP PICK
A bit contrarian. Not a consensus long. Unique. Largest operator of for-profit hospitals in the US, plus emergency and ambulatory care centres. Key component of healthcare delivery. Executing exceptionally well over 6-7 years. Labour costs have been a drag, but this is abating. Yield is 1.07%. (Analysts’ price target is $257.67)
Unspecified

It is the largest hospital operator in the U.S. It is a defensive stock with consistent revenue but not consistent costs. It will continue to have issues with this and he wants to see more visibility on costs. It executes well.

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

HCA is one of the largest hospital operators in the US, holding 28% of the market share.  It managed the pandemic turmoil better than any other operator.  Given the enormous capital requirements there is a high barrier to entry in the space.  It trades at 18x earnings and management has been aggressively buying back shares and retiring debt.  We recommend setting a stop-loss at $337, looking to achieve $465 -- upside potential of 18%.  Yield 0.6% 

(Analysts’ price target is $395.00)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Aug 29/24, Up 2.4%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with HCA is progressing well.  To remain disciplined, we recommend trailing up the stop (from $337) to $373 at this time.

BUY ON WEAKNESS

He's been recommending this post-Covid, because it's been benefitting from the huge bounce back in medical procedures that were delayed. HCA just made a new all-time high. But last Friday it reported a shocking top and bottom line miss. Is down 13% in the past week, but this is an opportunity. HCA missed only slightly, not the end of the world. Hurricanes hit revenues by $200-300 million and 60-90 cents per share, a one-off impact. HCA reaffirmed its full-year forecast, though

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Aug 29/24, Down 5%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with HCA has triggered its stop at $373.  To remain disciplined, we recommend covering the position at this time.